Pioglitazone Suppresses Urothelial Tumorigenesis <i>In Vitro</i>: A Potential Chemopreventive Agent
PIO has a chemopreventive effect on urothelial tumorigenesis, supporting its potential use as a preferred anti-diabetic agent for patients with a risk or history of urothelial carcinoma.
Authors
- Takuo Matsukawa (ORCID: https://orcid.org/0009-0009-4418-399X)
- Naohiro Fujimoto (ORCID: https://orcid.org/0000-0002-5256-6415)
- Eiji Kashiwagi (ORCID: https://orcid.org/0000-0001-9424-3764)
- Yujiro Nagata (ORCID: https://orcid.org/0000-0001-6815-4266)
- Nguyen Thu Quynh (ORCID: https://orcid.org/0000-0001-7468-9718)
Institutions
- University of Occupational and Environmental Health Japan (JP)
- Kurosawa Hospital (JP)
Publication Details
- Journal
- Cancer Genomics & Proteomics
- Published
- 2025-08-29
- DOI
- https://doi.org/10.21873/cgp.20534
- Primary Topic
- Cancer, Lipids, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- University of Occupational and Environmental Health